KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) Enterprise Value (2016 - 2025)

Repligen (RGEN) has disclosed Enterprise Value for 16 consecutive years, with -$969.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 27.93% to -$969.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$969.2 million, a 27.93% decrease, with the full-year FY2025 number at -$969.2 million, down 27.93% from a year prior.
  • Enterprise Value was -$969.2 million for Q4 2025 at Repligen, down from -$748.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$573.4 million in Q3 2022 to a low of -$969.2 million in Q4 2025.
  • A 5-year average of -$695.4 million and a median of -$703.0 million in 2025 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: crashed 34.33% in 2021, then grew 18.77% in 2022.
  • Repligen's Enterprise Value stood at -$603.8 million in 2021, then decreased by 3.3% to -$623.8 million in 2022, then decreased by 20.45% to -$751.3 million in 2023, then decreased by 0.84% to -$757.6 million in 2024, then decreased by 27.93% to -$969.2 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Enterprise Value are -$969.2 million (Q4 2025), -$748.7 million (Q3 2025), and -$708.9 million (Q2 2025).